Unusual Rise in Cases of Guillain-Barre Syndrome in Mumbai

▴ Guillain-Barre Syndrome
GBS typically follows a viral or bacterial infection, where the immune system mistakenly attacks the body itself. Dr Nilesh Chaudhary, a neurologist at Hiranandani Hospital, explained that it starts with muscle weakness, numbness, or tingling as the nerves come under attack. It can progress to paralysis, requiring a longer recovery period.

Mumbai is experiencing an unusual increase in cases of Guillain-Barre syndrome (GBS), a rare autoimmune neurological disorder. GBS occurs when the body's immune system attacks the peripheral nervous system.

According to a report by Times of India, doctors have observed that the number of GBS cases has risen by 30-50% compared to the usual numbers during the monsoon season. Neurologists have noticed a significant increase in both outpatient cases and admissions.BYL Nair Hospital, operated by the city, has treated over 15 GBS cases in just a month, with six patients currently under treatment.

Prominent private hospitals like Kokilaben Hospital in Andheri and Bhatia Hospital in Tardeo have each treated more than a dozen GBS cases in July. Other hospitals like Fortis and Lilavati are also treating three to five patients each. The encouraging news is that none of these hospitals have reported any fatalities.

The Link to Viral Infections and Travel History

The exact reason behind this surge in GBS cases remains uncertain. Doctors speculate that it might be due to a broader increase in viral infections. Dr Rahul Chakor, head of the neurology department at Nair Hospital, mentioned that almost all his GBS patients developed the condition shortly after recovering from a viral or gastrointestinal infection. This rise in cases has affected people of all ages and genders.

GBS typically follows a viral or bacterial infection, where the immune system mistakenly attacks the body itself. Dr Nilesh Chaudhary, a neurologist at Hiranandani Hospital, explained that it starts with muscle weakness, numbness, or tingling as the nerves come under attack. It can progress to paralysis, requiring a longer recovery period.

Varied Presentations and Concerning Cases

Dr. Ashish Gosar, a neurologist at Bhatia Hospital, noted that several versions of GBS are emerging. Unlike the classic pattern where weakness starts from the lower limbs and moves upward, some presentations are atypical. The severity seems to be more pronounced in younger patients, with some cases progressing rapidly due to early cranial nerve involvement and upper limb weakness.

Hospitals are witnessing cases where patients require critical care and ventilatory support due to weak respiratory muscles. Hospitals like Fortis Hiranandani and Kokilaben Ambani Hospital have reported cases that demand plasma exchange therapy and mechanical ventilation.

The Road to Recovery and Further Research

Despite the alarming surge, the majority of patients are recovering over six to twelve months. Dr. Girish Soni of Lilavati Hospital emphasized that this surge needs to be documented. The treatment costs are substantial, especially in private hospitals, where patients may require immunoglobulins worth Rs 2-3 lakh along with supportive therapies.

Interestingly, there has been an increase in autoimmune conditions post the Covid-19 pandemic. Dr. Chakor stated that if this surge is somehow linked to GBS, it would warrant further in-depth research.

As this situation unfolds, it's crucial to be aware of the symptoms and seek timely medical attention. Monitoring breathing, heart rate, and blood pressure for anyone suspected of having GBS is essential. Stay informed and prioritize your health in these uncertain times.

Tags : #guillainbarresyndrome #bacteria #bacterialinfection #immunesystem #neuro #nerveproblem #paralysis #mumbai #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026
Fatty Liver Disease: Connecting Metabolic Health With Liver CareNovember 12, 2026
Chronic Kidney Disease: Understanding Risk Assessment and Early MonitoringNovember 12, 2026
Advanced OCTA Diagnostics in Age-Related Macular Degeneration (AMD)November 11, 2026
Advanced Diagnostics in Age-Related Macular Degeneration (AMD): Optical Coherence Tomography Angiography (OCTA)November 11, 2026
PCOS Care in India: Understanding Diagnosis and Long-Term MonitoringNovember 11, 2026
Thyroid Health: Making Sense of Testing and Follow-UpNovember 11, 2026